Response Genetics, Inc
RGDXQ
$0.00
$0.000.00%
OTC PK
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Net Income | -17.77% | 6.36% | -16.08% | 10.43% | -10.17% |
| Total Depreciation and Amortization | -1.69% | -4.54% | -7.08% | 6.52% | 12.57% |
| Total Amortization of Deferred Charges | -9.25% | 49.78% | -- | -- | -- |
| Total Other Non-Cash Items | 12.93% | -4.63% | 18.02% | 6.92% | -19.56% |
| Change in Net Operating Assets | 95.90% | 15.82% | -49.01% | -44.71% | -1,058.75% |
| Cash from Operations | 49.44% | 13.55% | -35.09% | -2.89% | -201.69% |
| Capital Expenditure | 86.89% | -130.65% | 197.39% | -104.33% | 83.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | 63.92% | -100.69% | 65.39% |
| Cash from Investing | 85.28% | -133.06% | 154.48% | -102.91% | 80.48% |
| Total Debt Issued | 283.45% | -95.24% | 1,522.78% | -- | -- |
| Total Debt Repaid | -87.34% | 23.38% | 18.79% | -3.13% | 12.25% |
| Issuance of Common Stock | -- | -- | -100.00% | -68.93% | -99.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,719.48% | -100.38% | 1,670.94% | 1,604.62% | -100.63% |
| Foreign Exchange rate Adjustments | -196.21% | 1,605.88% | 270.00% | 95.50% | -2,366.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.95% | -197.75% | 235.56% | 11.66% | -189.69% |